Cautious exuberance after the first quarter
Nature Publishing Group
Nature Archives 1869 - 2009
Process Engineering, Biotechnology, Nutrition Technology
[Auszug] Coming off a year that brought biotech investment back up near 2000 boom levels, the first quarter of 2004 (1Q04) registered continued high investor confidence. But industry observers see a potential dark cloud looming in the shape of hype and a leaderless US Food and Drug Administration (FDA; ...
Type of Medium: